SNPsig® EscapePLEX SARS-CoV-2 – Lab Innovations UK
2025 (7)
Primerdesign

Share:

Facebook
Twitter
LinkedIn
WhatsApp

Description

The SNPsig® EscapePLEX SARS-CoV-2, is the first in the market to detect the mutations E484K, K417N, K417T, and P681R, as well as two SARS-CoV 2 targets, to confirm positivity (ORF 1ab and M gene), in one kit.

Contact this exhibitor

Scroll to Top